Posted in | News | Business

Graco to Acquire Illinois Tool Works’ Finishing Equipment Businesses

Illinois Tool Works (ITW) declared that it has signed a contract with Graco to sell its finishing equipment businesses. The transaction amount is $650 million and the sale is likely to happen after completing regulatory evaluations.

The company’s finishing equipment businesses include paint spray systems and technologies for numerous industrial segments and applications. The company’s main businesses are Binks, Gema, BGK, DeVilbiss and Ransburg, who are major players in drying technologies, wet industrial finishing and powder paint devices.

In 2010, the revenue obtained from the finishing business was $305 million. ITW plans to use the after-tax profits earned from the sale to buy back shares as part of its repurchase program.

David B. Speer, Chairman and CEO of ITW, stated that the company’s finishing businesses provide a wide range of global brands that depict a significant asset. He added that the sale offers an excellent opportunity to the finishing businesses to maximize their long-standing development and profitability.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Graco Inc.. (2019, February 09). Graco to Acquire Illinois Tool Works’ Finishing Equipment Businesses. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=28867.

  • MLA

    Graco Inc.. "Graco to Acquire Illinois Tool Works’ Finishing Equipment Businesses". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=28867>.

  • Chicago

    Graco Inc.. "Graco to Acquire Illinois Tool Works’ Finishing Equipment Businesses". AZoM. https://www.azom.com/news.aspx?newsID=28867. (accessed November 22, 2024).

  • Harvard

    Graco Inc.. 2019. Graco to Acquire Illinois Tool Works’ Finishing Equipment Businesses. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=28867.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.